Previous close | 8.57 |
Open | 8.61 |
Bid | 0.00 x 800 |
Ask | 0.00 x 900 |
Day's range | 8.55 - 8.97 |
52-week range | 7.12 - 14.59 |
Volume | |
Avg. volume | 522,482 |
Market cap | 447.386M |
Beta (5Y monthly) | 1.40 |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
NEW YORK, June 27, 2024--AREX Capital Management, LP (together with its affiliates, "AREX"), the beneficial owner of approximately 4.9% of the outstanding common shares of Enhabit, Inc. (NYSE: EHAB) ("Enhabit" or the "Company"), today issued a presentation detailing the AREX Slate’s comprehensive plan to turn around Enhabit’s operational performance and reduce costs, which AREX believes could increase EBITDA by 50%.
DALLAS, June 24, 2024--Enhabit, Inc. (NYSE: EHAB), ("Enhabit" or the "Company"), a leading home health and hospice provider, today sent a letter to stockholders in connection with its upcoming 2024 Annual Meeting of Stockholders (the "2024 Annual Meeting") scheduled for July 25, 2024. Stockholders of record as of the close of business on June 5, 2024 are entitled to vote at the 2024 Annual Meeting.
NEW YORK, June 17, 2024--AREX Capital Management, LP (together with its affiliates, "AREX" or "we"), the beneficial owner of approximately 4.9% of the outstanding common shares of Enhabit, Inc. (NYSE: EHAB) ("Enhabit"), today issued an open letter to its fellow stockholders regarding the misleading statements in Enhabit’s recent communications.